Articles
Nanoengineering Artificial Lipid Envelopes Around Adenovirus by Self-Assembly
Purchase the full-text
- PDF/HTML,
figures/images,
references and tables,
(where available)
Abstract

We have developed a novel, reproducible, and facile methodology for the construction of artificial lipid envelopes for adenoviruses (Ad) by self-assembly of lipid molecules around the viral capsid. No alteration of the viral genome or conjugation surface chemistry at the virus capsid was necessary, therefore difficulties in production and purification associated with generating most surface-modified viruses can be eliminated. Different lipid bilayer compositions produced artificially enveloped Ad with physicochemical and biological characteristics determined by the type of lipid used. Physicochemical characteristics such as vector size, degree of aggregation, stability, and surface charge of the artificially enveloped Ad were correlated to their biological (gene transfer) function. In monolayer cell cultures, binding to the coxsackie and adenovirus receptor (CAR) was blocked using a zwitterionic envelope, whereas enhanced binding to the cell membrane was achieved using a cationic envelope. Envelopment of Ad by both zwitterionic and cationic lipid bilayers led to almost complete ablation of gene expression in cell monolayers, due to blockage of virion endosomal escape. Alternatively, artificial Ad envelopes built from lipid bilayers at the fluid phase in physiological conditions led to enhanced penetration of the vectors inside a three-dimensional tumor spheroid cell culture model and delayed gene expression in the tumor spheroid compared to nonenveloped adenovirus. These results indicate that construction of artificial envelopes for nonenveloped viruses by lipid bilayer wrapping of the viral capsids constitutes a general strategy to rationally engineer viruses at the nanoscale with control over their biological properties.
Keywords:
nanomedicine; gene therapy; viral envelope; nonenveloped virus; liposome; nanobiotechnology; nanotechnology; nanoengineering; biomembraneCiting Articles
Citation data is made available by participants in CrossRef's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search in SciFinder.
This article has been cited by 2 ACS Journal articles (2 most recent appear below).

Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine
Wafa’ T. Al-Jamal and Kostas KostarelosAccounts of Chemical Research2011 44 (10), 1094-1104Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine
Wafa’ T. Al-Jamal and Kostas KostarelosAccounts of Chemical Research2011 44 (10), 1094-1104For decades, clinicians have used liposomes, self-assembled lipid vesicles, as nanoscale systems to deliver encapsulated anthracycline molecules for cancer treatment. The more recent proposition to combine liposomes with nanoparticles remains at the ...

Adenovirus in a Synthetic Membrane Wrapper: An Example of Hybrid Vigor?
David H. ThompsonACS Nano2008 2 (5), 821-826Adenovirus in a Synthetic Membrane Wrapper: An Example of Hybrid Vigor?
David H. ThompsonACS Nano2008 2 (5), 821-826The most pressing needs for the development of efficient non-viral carrier systems are improvements in targeting efficiency and selectivity.
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue May 27, 2008
- Article ASAPApril 30, 2008
- Received: January 29, 2008
Accepted: April 07, 2008
Cart

ACS
Network






